219 related articles for article (PubMed ID: 3266473)
1. Effects of calcium blockers on ventricular fibrillation during acute myocardial infarction.
Da-Luz PL; Da-Silveira MC; Murad-Neto A; Pileggi F
Braz J Med Biol Res; 1988; 21(4):801-10. PubMed ID: 3266473
[TBL] [Abstract][Full Text] [Related]
2. Effects of verapamil and bepridil on occlusion and reperfusion arrhythmias in the canine heart.
Pelleg A; Pardo Y; Belhassen B; Shargordsky B; Chagnac A; Laniado S
Cardiology; 1985; 72(4):193-201. PubMed ID: 3876883
[TBL] [Abstract][Full Text] [Related]
3. Effects of verapamil and magnesium sulfate on electrophysiologic changes during acute myocardial ischemia and following reperfusion in dogs: comparative effects of administration by intravenous and coronary sinus retroperfusion routes.
Yamamoto K; Bando S
Angiology; 1996 Jun; 47(6):557-68. PubMed ID: 8678330
[TBL] [Abstract][Full Text] [Related]
4. Effects of bepridil on regional myocardial ischemia and comparison with verapamil.
Reifart N; Marston W; Zierler MK; Taylor AD; Kaltenbach M; Khuri SF
Am J Cardiol; 1986 Sep; 58(6):541-6. PubMed ID: 3092628
[TBL] [Abstract][Full Text] [Related]
5. Calcium antagonists and acute myocardial ischemia: comparative effects of gallopamil and nifedipine on ischemia-induced and reperfusion-induced ventricular arrhythmias, epicardial conduction times, and ventricular fibrillation thresholds.
Gülker H; Haverkamp W; Hindricks G; Bender F
Cardiovasc Drugs Ther; 1987 Dec; 1(4):367-76. PubMed ID: 3154673
[TBL] [Abstract][Full Text] [Related]
6. [Comparative studies on the anti-arrhythmic and anti-fibrillatory effectiveness of verapamil and nifedipine following acute coronary artery occlusion and reperfusion].
Gülker H; Thale J; Brisse B; Bender F
Z Kardiol; 1984 Aug; 73(8):515-24. PubMed ID: 6495811
[TBL] [Abstract][Full Text] [Related]
7. Effects of bepridil on regional and global myocardial ischemia/reperfusion-induced injury.
Jackson CV; Mitsos SE; Simpson PJ; Driscoll EM; Lucchesi BR
Pharmacology; 1985; 30(6):320-32. PubMed ID: 3874404
[TBL] [Abstract][Full Text] [Related]
8. Ventricular fibrillation in acute experimental myocardial ischemia: protection by magnesium sulfate.
Barros LF; Da-Luz PL; Silveira MC; Chagas AC; Pileggi F
Braz J Med Biol Res; 1988; 21(4):791-9. PubMed ID: 3240378
[TBL] [Abstract][Full Text] [Related]
9. Potent antifibrillatory effect of combined blockade of calcium channels and 5-HT2 receptors with nexopamil during myocardial ischemia and reperfusion in dogs: comparison to diltiazem.
Nearing BD; Hutter JJ; Verrier RL
J Cardiovasc Pharmacol; 1996 Jun; 27(6):777-87. PubMed ID: 8761843
[TBL] [Abstract][Full Text] [Related]
10. Calcium antagonists and prevention of ventricular fibrillation induced by transient or persistent ischemia.
Timour Q; Bui-Xuan B; Aupetit JF; Freysz M; Evreux JC; Faucon G
Jpn Heart J; 1997 Mar; 38(2):237-51. PubMed ID: 9201111
[TBL] [Abstract][Full Text] [Related]
11. Renal denervation suppresses ventricular arrhythmias during acute ventricular ischemia in pigs.
Linz D; Wirth K; Ukena C; Mahfoud F; Pöss J; Linz B; Böhm M; Neuberger HR
Heart Rhythm; 2013 Oct; 10(10):1525-30. PubMed ID: 23851058
[TBL] [Abstract][Full Text] [Related]
12. Myocardial protection by verapamil and reperfusion following coronary occlusion.
da-Luz PL; Silveira MC; Chagas AC; Pileggi F
Braz J Med Biol Res; 1990; 23(3-4):317-24. PubMed ID: 2094544
[TBL] [Abstract][Full Text] [Related]
13. Epicardial controlled-release verapamil prevents ventricular tachycardia episodes induced by acute ischemia in a canine model.
Siden R; Kadish A; Flowers W; Kutas L; Bieneman BK; DePietro J; Jenkins JP; Gallagher KP; Levy RJ
J Cardiovasc Pharmacol; 1992 May; 19(5):798-809. PubMed ID: 1381779
[TBL] [Abstract][Full Text] [Related]
14. Reduction of myocardial infarct size in rats under the effect of bepridil.
Richard V; de Leiris J
Adv Myocardiol; 1985; 6():563-72. PubMed ID: 3873103
[TBL] [Abstract][Full Text] [Related]
15. Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker.
Bui-Xuan B; Aupetit JF; Freysz M; Loufoua-Moundanga J; Faucon G; Timour Q
Arch Int Pharmacodyn Ther; 1996; 331(3):246-62. PubMed ID: 9124997
[TBL] [Abstract][Full Text] [Related]
16. Inadequate ischaemia-selectivity limits the antiarrhythmic efficacy of mibefradil during regional ischaemia and reperfusion in the rat isolated perfused heart.
Farkas A; Qureshi A; Curtis MJ
Br J Pharmacol; 1999 Sep; 128(1):41-50. PubMed ID: 10498833
[TBL] [Abstract][Full Text] [Related]
17. Verapamil and tiapamil in prevention of ventricular fibrillation in pigs with coronary ligation. Comparative effects on left ventricular function.
Muller CA; Opie LH; Hamm CW; Peisach M; Pineda CA; Thandroyen FT
Circulation; 1988 Jul; 78(1):227-32. PubMed ID: 3383406
[TBL] [Abstract][Full Text] [Related]
18. Acute coronary artery occlusion-reperfusion arrhythmias in pigs: antiarrhythmic and antifibrillatory evaluation of verapamil, nifedipine, prenylamine and propranolol.
Bergey JL; Wendt RL; Nocella K; McCallum JD
Eur J Pharmacol; 1984 Jan; 97(1-2):95-103. PubMed ID: 6698112
[TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic and electrophysiologic effects of bepridil in chronically infarcted conscious dogs.
Lynch JJ; Montgomery DG; Ventura A; Lucchesi BR
J Pharmacol Exp Ther; 1985 Jul; 234(1):72-80. PubMed ID: 3874285
[TBL] [Abstract][Full Text] [Related]
20. Ro 40-5967, a novel calcium channel antagonist, protects against ventricular fibrillation.
Billman GE
Eur J Pharmacol; 1992 Dec; 229(2-3):179-87. PubMed ID: 1490522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
